Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Lung Neoplasms 4 Motor Activity 3 Breast Neoplasms 3 Rehabilitation 2 Carcinoma, Non-Small-Cell Lung 2 Trismus 1 Sleep Initiation and Maintenance Disorders 1 Sarcoma 1 Pulmonary Disease, Chronic Obstructive 1 Pancreatic Diseases 1 Pain, Postoperative 1 Pain 1 Myelodysplastic Syndromes 1 Mouth Neoplasms 1 Melanoma 1 Malignant Female Reproductive System Neoplasm 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Fatigue 1 Dyspnea 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cardiotoxicity 1 Breast Cancer Lymphedema 1 Brain Neoplasms 1 Anaplasia 1 Agnosia 1 Advanced Cancer 1

Interventions

Cisplatin 141 Radiotherapy 115 Cetuximab 95 Docetaxel 69 Radiotherapy, Intensity-Modulated 55 Carboplatin 47 pembrolizumab 46 Surveys and Questionnaires 46 Paclitaxel 41 Fluorouracil 39 Radiation 29 Blood Specimen Collection 27 Drug Therapy 26 Erlotinib Hydrochloride 23 Nivolumab 21 Surgical Procedures, Operative 17 Standard of Care 16 Magnetic Resonance Spectroscopy 16 Radiosurgery 14 Pemetrexed 14 Gemcitabine 14 Everolimus 13 Celecoxib 13 durvalumab 12 Low-Level Light Therapy 12 Immunohistochemistry 12 Cyclophosphamide 12 Capecitabine 12 Amifostine 12 Chemoradiotherapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Head and Neck Neoplasms × Rehabilitation × Clear all

NCT03206242 2017-07-02

HNC

Chang Gung Memorial Hospital

Head and Neck Neoplasms, Mouth Neoplasms, Pain, Trismus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡